LEI; Huangshu

Patent Applications and Registrations

Patent applications and USPTO patent grants for LEI; Huangshu.The latest application filed is for "crystal form i of canagliflozin and preparation method thereof".

Company Profile

0.14.17

LEI; Huangshu - Chongqing CN
Lei; Huangshu - Cambridge MA US
Lei; Huangshu - Durham NC US
Lei; Huangshu - Waltham MA
Lei; Huangshu - Ann Arbor MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystal Form I Of Canagliflozin And Preparation Method Thereof App 20170342061 - WANG; Fei ; et al.	2017-11-30
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH Grant 8,957,068 - Caferro , et al. February 17, 2	2015-02-17
3-pyrimidin-4-yl-oxazolidin-2-ones As Inhibitors Of Mutant Idh App 20140235620 - Caferro; Thomas Raymond ; et al.	2014-08-21
(S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-4-(4-fluorobenzoyl)-thiazol-2-yl]pyrro- lidin-1-yl}-2-oxoethyl)-2-methylamino-propionamide, or pharmaceutically acceptable salts thereof and their uses Grant 8,552,003 - Charest , et al. October 8, 2	2013-10-08
SMAC peptidometics useful as IAP inhibitors Grant 8,546,336 - Chen , et al. October 1, 2	2013-10-01
Smac Peptidometics Useful As Iap Inhibitors App 20130005663 - CHAREST; Mark G. ; et al.	2013-01-03
Pyrrolydine derivatives as IAP inhibitors Grant 8,044,209 - Charest , et al. October 25, 2	2011-10-25
2-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino] benzamide derivatives as IGF-1R inhibitors for the treatment of cancer Grant 7,981,903 - Chamberlain , et al. July 19, 2	2011-07-19
Organic Compounds App 20110065726 - CHEN; Zhuoliang ; et al.	2011-03-17
Pyrrolydine Derivatives as IAP Inhibitors App 20110015232 - Charest; Mark G. ; et al.	2011-01-20
2-[2--1H-Pyrrolo[2,3-D]Pyrimidin-4-YL)Amino] Benzamide Derivatives As IGF-1R Inhibitors For The Treatment Of Cancer App 20100204196 - Chamberlain; Stanley Dawes ; et al.	2010-08-12
Androgen modulators Grant 7,670,613 - Hu , et al. March 2, 2	2010-03-02
Androgen Modulators App 20100048517 - Hu; Lain-Yen ; et al.	2010-02-25
Androgen receptor modulators Grant 7,576,128 - Hu , et al. August 18, 2	2009-08-18
Androgen Modulators App 20090192202 - Hu; Lain-Yen ; et al.	2009-07-30
Androgen Modulators App 20090105349 - Barvian; Nicole Chantel ; et al.	2009-04-23
Androgen modulators Grant 7,507,860 - Hu , et al. March 24, 2	2009-03-24
Androgen modulators Grant 7,473,711 - Hu , et al. January 6, 2	2009-01-06
Androgen modulators App 20070197642 - Hu; Lain-Yen ; et al.	2007-08-23
Androgen modulators App 20070197641 - Hu; Lain-Yen ; et al.	2007-08-23
Androgen receptor modulators App 20070129409 - Hu; Lain-Yen ; et al.	2007-06-07
Androgen modulators App 20060009427 - Hu; Lain-Yen ; et al.	2006-01-12
Androgen receptor modulators App 20050182132 - Hu, Lain-Yen ; et al.	2005-08-18
Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases App 20050014841 - Hu, Lain-Yen ; et al.	2005-01-20
Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases Grant 6,809,119 - Hu , et al. October 26, 2	2004-10-26
Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases Grant 6,632,831 - Hays , et al. October 14, 2	2003-10-14
Branched Chain Amino Acid-dependent Aminotransferase Inhibitors And Their Use In The Treatment Of Neurodegenerative Diseases App 20030162779 - Hays, Sheryl Jeanne ; et al.	2003-08-28
Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases App 20030149110 - Hu, Lain-Yen ; et al.	2003-08-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.